The Efficacy of Combined Therapy of Regorafenib with Detoxicating and Stasis Softening Chinese Herbal Spleen Tonics in Mid-/Late-Stage Hepatocellular Carcinoma

<div>Cell viability and Transwell assay of HCCLM3 cells treated with regorafenib and/or DSS-splenic tonics. (a) MTT assay result, absorbance at 570 nm at 24 h, 48 h and 72 h posttreatment; (b) Transwell invasion assay were subjected to detect the migration and invasion capacity of HCCLM3 cells treated with regorafenib and/or DSS.</div>

Contrast Media & Molecular Imaging

fig1

Figure 1

Figure 1: The Efficacy of Combined Therapy of Regorafenib with Detoxicating and Stasis Softening Chinese Herbal Spleen Tonics in Mid-/Late-Stage Hepatocellular Carcinoma 

Figure 1 | The Efficacy of Combined Therapy of Regorafenib with Detoxicating and Stasis Softening Chinese Herbal Spleen Tonics in Mid-/Late-Stage Hepatocellular Carcinoma 